MRK
Income statement / Annual
Last year (2024), Merck & Co., Inc.'s total revenue was $64.17 B,
an increase of 6.74% from the previous year.
In 2024, Merck & Co., Inc.'s net income was $17.12 B.
See Merck & Co., Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$64.17 B |
$60.12 B |
$59.28 B |
$48.70 B |
$41.52 B |
$39.12 B |
$42.29 B |
$40.12 B |
$39.81 B |
$39.50 B |
| Cost of Revenue |
$15.19 B
|
$16.13 B
|
$17.41 B
|
$13.63 B
|
$13.62 B
|
$12.02 B
|
$13.51 B
|
$12.91 B
|
$14.03 B
|
$14.93 B
|
| Gross Profit |
$48.98 B
|
$43.99 B
|
$41.87 B
|
$35.08 B
|
$27.90 B
|
$27.11 B
|
$28.79 B
|
$27.21 B
|
$25.78 B
|
$24.56 B
|
| Gross Profit Ratio |
0.76
|
0.73
|
0.71
|
0.72
|
0.67
|
0.69
|
0.68
|
0.68
|
0.65
|
0.62
|
| Research and Development Expenses |
$17.94 B
|
$30.53 B
|
$13.55 B
|
$12.25 B
|
$13.40 B
|
$9.72 B
|
$9.75 B
|
$10.34 B
|
$10.26 B
|
$6.70 B
|
| General & Administrative Expenses |
$7.70 B
|
$7.58 B
|
$7.47 B
|
$7.40 B
|
$6.77 B
|
$0.00
|
$0.00
|
$244.00 M
|
$255.00 M
|
$0.00
|
| Selling & Marketing Expenses |
$2.40 B
|
$2.30 B
|
$2.20 B
|
$2.00 B
|
$1.80 B
|
$0.00
|
$0.00
|
$9.83 B
|
$9.76 B
|
$10.31 B
|
| Selling, General & Administrative Expenses |
$10.10 B
|
$9.88 B
|
$9.67 B
|
$9.40 B
|
$8.57 B
|
$9.46 B
|
$10.10 B
|
$10.07 B
|
$10.02 B
|
$10.31 B
|
| Other Expenses |
$716.00 M
|
$620.00 M
|
$373.00 M
|
$231.00 M
|
$386.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$28.75 B
|
$41.04 B
|
$23.59 B
|
$21.88 B
|
$22.35 B
|
$19.18 B
|
$19.85 B
|
$20.41 B
|
$20.28 B
|
$17.02 B
|
| Cost And Expenses |
$43.95 B
|
$57.16 B
|
$41.00 B
|
$35.51 B
|
$35.97 B
|
$31.20 B
|
$33.36 B
|
$33.33 B
|
$34.31 B
|
$31.95 B
|
| Interest Income |
$415.00 M
|
$365.00 M
|
$157.00 M
|
$36.00 M
|
$59.00 M
|
$274.00 M
|
$343.00 M
|
$385.00 M
|
$328.00 M
|
$289.00 M
|
| Interest Expense |
$1.27 B
|
$1.15 B
|
$962.00 M
|
$806.00 M
|
$831.00 M
|
$893.00 M
|
$772.00 M
|
$754.00 M
|
$693.00 M
|
$672.00 M
|
| Depreciation & Amortization |
$4.50 B
|
$3.87 B
|
$3.91 B
|
$3.21 B
|
$3.49 B
|
$3.31 B
|
$4.52 B
|
$4.68 B
|
$5.47 B
|
$6.38 B
|
| EBITDA |
$25.71 B |
$6.91 B |
$21.32 B |
$17.90 B |
$10.18 B |
$11.37 B |
$13.99 B |
$11.95 B |
$10.82 B |
$12.45 B |
| EBITDA Ratio |
0.4
|
0.11
|
0.36
|
0.37
|
0.25
|
0.29
|
0.33
|
0.3
|
0.27
|
0.32
|
| Operating Income Ratio |
0.32
|
0.05
|
0.31
|
0.27
|
0.13
|
0.2
|
0.21
|
0.17
|
0.14
|
0.19
|
| Total Other Income/Expenses Net |
-$285.00 M
|
-$1.07 B
|
-$1.84 B
|
$680.00 M
|
$315.00 M
|
-$755.00 M
|
-$230.00 M
|
-$276.00 M
|
-$840.00 M
|
-$2.15 B
|
| Income Before Tax |
$19.94 B
|
$1.89 B
|
$16.44 B
|
$13.88 B
|
$5.86 B
|
$7.17 B
|
$8.70 B
|
$6.52 B
|
$4.66 B
|
$5.40 B
|
| Income Before Tax Ratio |
0.31
|
0.03
|
0.28
|
0.28
|
0.14
|
0.18
|
0.21
|
0.16
|
0.12
|
0.14
|
| Income Tax Expense |
$2.80 B
|
$1.51 B
|
$1.92 B
|
$1.52 B
|
$1.34 B
|
$1.57 B
|
$2.51 B
|
$4.10 B
|
$718.00 M
|
$942.00 M
|
| Net Income |
$17.12 B
|
$365.00 M
|
$14.52 B
|
$13.05 B
|
$7.07 B
|
$9.84 B
|
$6.22 B
|
$2.39 B
|
$3.92 B
|
$4.44 B
|
| Net Income Ratio |
0.27
|
0.01
|
0.24
|
0.27
|
0.17
|
0.25
|
0.15
|
0.06
|
0.1
|
0.11
|
| EPS |
6.76 |
0.14 |
5.73 |
5.16 |
2.79 |
3.84 |
2.4 |
0.95 |
2.07 |
1.6 |
| EPS Diluted |
6.74 |
0.14 |
5.71 |
5.14 |
2.78 |
3.82 |
2.32 |
0.93 |
2.04 |
1.56 |
| Weighted Average Shares Out |
$2.53 B
|
$2.61 B
|
$2.53 B
|
$2.53 B
|
$2.53 B
|
$2.57 B
|
$2.59 B
|
$2.70 B
|
$2.75 B
|
$2.78 B
|
| Weighted Average Shares Out Diluted |
$2.54 B
|
$2.55 B
|
$2.54 B
|
$2.54 B
|
$2.54 B
|
$2.58 B
|
$2.68 B
|
$2.75 B
|
$2.79 B
|
$2.84 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
